Company / Revenue
Arcturus Therapeutics Holdings Inc. Revenue History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$82.0M
FY2025
5-year range
$12.4M / $166.8M
FY2021-FY2025
Trend
-46.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $167M to $82M over the past 2 years.
Based on SEC 10-K filings.
$82M in FY2025 with a 5-year CAGR of +39.1%.
Declined from $167M to $82M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +87.9%
- 5-Year CAGR
- +39.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +39.1%, indicating consistent growth.
- In FY2025, revenue decreased 46.1% year-over-year.
- Peak revenue was recorded in FY2023.
- Lowest revenue in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $82.0M | -46.1% |
| FY2024 | $152.3M | -8.7% |
| FY2023 | $166.8M | +1249.6% |
| FY2022 | $12.4M | +0.0% |
| FY2021 | $12.4M | -21.5% |
| FY2020 | $15.8M | +0.0% |
| FY2019 | $15.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026